Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 5, 2007 - Issue 1
Submit an article Journal homepage
41
Views
19
CrossRef citations to date
0
Altmetric
Review

Role of integrase inhibitors in the treatment of HIV disease

Lucia Palmisano Istituto Superiore di Sanità, Department of Drug Research and Evaluation, Viale Regina Elena 299, 00161 Rome, Italy. [email protected]
Pages 67-75 | Published online: 10 Jan 2014

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Pattarapan Panthong, Kingkan Bunluepuech, Nawong Boonnak, Prapaporn Chaniad, Somsak Pianwanit, Chatchai Wattanapiromsakul & Supinya Tewtrakul. (2015) Anti-HIV-1 integrase activity and molecular docking of compounds from Albizia procera bark. Pharmaceutical Biology 53:12, pages 1861-1866.
Read now
Mehdi Jalali-Heravi & Heshmatollah Ebrahimi-Najafabadi. (2011) The use of ladder particle swarm optimisation for quantitative structure–activity relationship analysis of human immunodeficiency virus-1 integrase inhibitors. Molecular Simulation 37:15, pages 1221-1233.
Read now

Articles from other publishers (17)

Nicole L. De La Mata, David A. Cooper, Darren Russell, Don Smith, Ian Woolley, Maree O. Sullivan, Stephen Wright & Matthew Law. (2016) Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study. Sexual Health 13:4, pages 335.
Crossref
Asa M. Margolis, Harry Heverling, Paul A. Pham & Andrew Stolbach. (2013) A Review of the Toxicity of HIV Medications. Journal of Medical Toxicology 10:1, pages 26-39.
Crossref
Gregory Sliwoski, Sandeepkumar Kothiwale, Jens Meiler & Edward W. LoweJr.Jr.. (2013) Computational Methods in Drug Discovery. Pharmacological Reviews 66:1, pages 334-395.
Crossref
Kingkan Bunluepuech, Teeratad Sudsai, Chatchai Wattanapiromsakul & Supinya Tewtrakul. (2011) Inhibition on HIV-1 Integrase Activity and Nitric Oxide Production of Compounds from Ficus glomerata . Natural Product Communications 6:8, pages 1934578X1100600.
Crossref
Chenzhong Liao, Christophe Marchand, Terrence R Burke Jr, Yves Pommier & Marc C Nicklaus. (2010) Authentic HIV-1 integrase inhibitors. Future Medicinal Chemistry 2:7, pages 1107-1122.
Crossref
Jamie D. Croxtall & Lesley J. Scott. (2010) Raltegravir. Drugs 70:5, pages 631-642.
Crossref
Jamie D. Croxtall & Susan J. Keam. (2009) Raltegravir. Drugs 69:8, pages 1059-1075.
Crossref
Brian A. Johns, Jason G. Weatherhead, Scott H. Allen, James B. Thompson, Edward P. Garvey, Scott A. Foster, Jerry L. Jeffrey & Wayne H. Miller. (2009) The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore. Bioorganic & Medicinal Chemistry Letters 19:6, pages 1802-1806.
Crossref
R. ter Heine, M.J.X. Hillebrand, H. Rosing, E.C.M. van Gorp, J.W. Mulder, J.H. Beijnen & A.D.R. Huitema. (2009) Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 49:2, pages 451-458.
Crossref
Marianne Harris. (2009) Raltegravir: Its use in the Treatment of HIV Infection. Clinical Medicine. Therapeutics 1, pages CMT.S32.
Crossref
Christoph BoeseckeLinda Gelgor. (2009) A Review of Raltegravir and its Use in HIV-1 Infection. Clinical Medicine. Therapeutics 1, pages CMT.S1985.
Crossref
Odile Launay. (2008) Thérapeutiques antirétrovirales : principes du traitement de l’infection par le VIH. La Presse Médicale 37:6, pages 1022-1032.
Crossref
Omar SuedPedro Cahn. (2008) Raltegravir: opening the road for integrase inhibitors in clinical practice. Future HIV Therapy 2:3, pages 217-227.
Crossref
Xue Zhi Zhao, Elena A. Semenova, B. Christie Vu, Kasthuraiah Maddali, Christophe Marchand, Stephen H. Hughes, Yves Pommier & Terrence R. BurkeJr.Jr.. (2007) 2,3-Dihydro-6,7-dihydroxy-1H-isoindol-1-one-Based HIV-1 Integrase Inhibitors. Journal of Medicinal Chemistry 51:2, pages 251-259.
Crossref
Stephen D LawnDavid J EdwardsRobin Wood. (2007) Concurrent drug therapy for tuberculosis and HIV infection in resource-limited settings: present status and future prospects. Future HIV Therapy 1:4, pages 387-398.
Crossref
Claudia Mugnaini, Suvi Rajamaki, Cristina Tintori, Federico Corelli, Silvio Massa, Myriam Witvrouw, Zeger Debyser, Veljko Veljkovic & Maurizio Botta. (2007) Toward novel HIV-1 integrase binding inhibitors: Molecular modeling, synthesis, and biological studies. Bioorganic & Medicinal Chemistry Letters 17:19, pages 5370-5373.
Crossref
Pedro Cahn & Omar Sued. (2007) Raltegravir: a new antiretroviral class for salvage therapy. The Lancet 369:9569, pages 1235-1236.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.